Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
Authors not listed
Massachusetts General Hospital · 2023
Abstract
The goal of this study is to objectively test one's sense of smell, called olfaction, in participants with Subjective Cognitive Concerns (SCC), Mild Cognitive Impairment, Mild Behavioral Impairment (MBI), and age-matched controls. The main question it aims to answer is whether the AROMHA Brain Health Test could serve as a predictive biomarker of neurodegenerative disorders. This understanding will aid in the development of a noninvasive, cost-effective diagnostic tool that reliably and specifically distinguishes disease and normal aging populations.
Participants will take the approximately 45-minute AROMHA Brain Health Smell Test where they will peel and sniff labels on the physical smell cards and answer questions on the web-based app relating to what they smelled. Participants will undergo tests for odor intensity, odor identification, odor discrimination, and episodic olfactory memory, but will not be provided the results of these tests.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Anonymous. (2023). Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD. <em>Massachusetts General Hospital</em>. https://clinicaltrials.gov/study/NCT05881239
Vancouver
Anonymous. Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD. Massachusetts General Hospital. 2023.
BibTeX
@misc{anon2023Digita,
title = {Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD},
author = {Anonymous},
journal = {Massachusetts General Hospital},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Zealand University Hospital 2026
Open access · US-GOV
Development of Deep Learning Models for Detection of Neurodegenerative Diseases Using Speech - a Danish Language-based Artificial Intelligence Study (DetectAI)
University of Calgary 2017
Open access · US-GOV
Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias: Harnessing Translational Physiology
Emory University 2022
Open access · US-GOV
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
Hadassah Medical Organization 2024
Open access · US-GOV
Is Cerebonin (Egb761) a Disease-modifying Therapy in Mild Cognitive Impairment
Georgetown University 2007
Open access · US-GOV
DC Longitudinal Study on Aging and Specimen Bank
Institute for Biomedical Research, CONICET 2023
Open access · US-GOV